According to a new report, published by KBV research, The Global Peripheral Artery Disease Market size is expected to reach $7.1 billion by 2031, rising at a market growth of 6.9% CAGR during the forecast period.
Peripheral artery disease (PAD) is characterized by the narrowing or blockage of the peripheral arteries, primarily those supplying the legs, due to atherosclerosis. In severe cases, critical limb ischemia can result in tissue damage and even amputation, as well as symptoms such as leg discomfort during walking (claudication) and numbness. Specifically, the prevalence of PAD is on the rise, particularly among geriatric populations, and it is a substantial health concern that negatively impacts millions of individuals worldwide.
The Drugs segment led the Global Peripheral Artery Disease Market by Product Type in 2023; thereby, achieving a market value of $4.1 billion by 2031. Pharmaceutical treatments for PAD are essential for managing symptoms, improving patient outcomes, and addressing the underlying causes of the disease. Medications such as antiplatelet agents, statins, and vasodilators are routinely prescribed to patients to prevent blood clots, lower cholesterol levels, and enhance blood flow, respectively.
The Hospitals segment is growing at a CAGR of 6.4 % during the forecast period. Complex and severe cases of PAD are effectively managed by specialized healthcare professionals and hospitals that are well-equipped with advanced medical technology. They offer comprehensive services, including diagnostic imaging, surgical interventions, and postoperative care, essential for effectively treating PAD patients.
Full Report: https://www.kbvresearch.com/peripheral-artery-disease-market/
The North America region dominated the Global Peripheral Artery Disease Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $2.6 billion by 2031. The Europe region is anticipated to grow at a CAGR of 6.5% during (2024 - 2031). Additionally, The Asia Pacific region would witness a CAGR of 7.8% during (2024 - 2031).
By Product Type
By End User
By Geography
Unique Offerings 
